generation of hla universal platelets for regenerative applications · antihla ab nc (ab only) shns...
TRANSCRIPT
![Page 1: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/1.jpg)
Generation of HLA universal platelets for regenerative applications
Constança Figueiredo
Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany
![Page 2: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/2.jpg)
IMGT/HLA database
12.672 HLA alleles
HLA loci are the most polymorphic of the entire human genome
A mean of 450 new alleles/ Year
![Page 3: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/3.jpg)
Structure of HLA class I and II molecules
HLA-AHLA-B
HLA-DRHLA-DP
HLA Class I HLA Class II
HLA-BHLA-C
HLA-DPHLA-DQ
![Page 4: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/4.jpg)
The function of HLA molecules
Antigen presentation
Efficient immune response against pathogens and cancer cells
![Page 5: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/5.jpg)
�HLA Antigens = Major Antigens
�Non-HLA Antigens = Minor Antigens = Presented Peptides
HLA variability is the major hurdle for transplantation
MHC/non-MHC
MismatchImmune response
(humoral/cellular) Rejection
![Page 6: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/6.jpg)
Standard Strategy to prevent rejection:Immunosuppression
Suppression of the recipient’s immune system
![Page 7: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/7.jpg)
Control HLA expression in a allele-, gene- or class-specific way.
In a clinical setting, this would allow to
1. develop tissues with low or no immunogenicity.
Aim
1. develop tissues with low or no immunogenicity.
2. decrease the risk of HLA-mediated post-transplanttissue/organ failure.
![Page 8: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/8.jpg)
Universal cells and tissues
Tissue(invisible)
CompetentImmune System
HLA TCR
(invisible)System
![Page 9: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/9.jpg)
Alternative Strategy to prevent rejection:Reducing the organ‘s immunogenicity
Reducing the organ’s Immunogenicity
![Page 10: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/10.jpg)
Gene silencing by RNA interference (RNAi):Small interfering RNA (siRNA)
Synthetic siRNA duplex
siRNA duplex
Cellular kinase
Andrew FireStanford University
Single-stranded siRNA in RNA-induced silencing complex (RISC)
Translational Block Mechanism Cleavage Mechanism
mRNA mRNA
Craig MelloUniversity of Massachusetts
Nobel Prize 2006
![Page 11: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/11.jpg)
Silencing of β2-microglobulin in rat Lew fibroblasts
Figueiredo et al. BioMed Res Int, 2013
![Page 12: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/12.jpg)
MHC silencing prolongs graft survival after allogeneic transplantation
Figueiredo et al. BioMed Res Int, 2013
![Page 13: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/13.jpg)
Role of platelets
� Maintain Haemostasis
� Secretory functions
� Modulation of immune responses� Modulation of immune responses
� Regulate proliferation
![Page 14: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/14.jpg)
Application of platelets in regenerative medicine
� Treatment of thrombocytopenia
� Wound healing
� Tissue remodelling� Tissue remodelling
� Drug carriers
![Page 15: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/15.jpg)
Thrombocytopenia
Characteristics
• Low platelet number
• Major bleeding complications
HLA-universal platelets
Treatment optionsTreatment optionsTreatment optionsTreatment options
Ex-vivo induced megakaryocyte
progenitors
TPO receptor agonistsAllogeneic platelets
Alloimmunization against HLA class I
antigens
� Platelet
refractorinessdue to HLA antibodies
Treatment optionsTreatment optionsTreatment optionsTreatment options
![Page 16: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/16.jpg)
In vitro production of Platelets to treat platelet transfusion refractoriness
![Page 17: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/17.jpg)
Thrombopoiesis
Thrombopoietin (TPO)
Stem cell factor (SCF), IL-3IL-6, IL-11
Cell division Platelets
Endomitosis
MEP CFU-MK Promegakaryoblast Megakaryocyte
Proplatelet producing megakaryocyte
CD41 (GPIIb/IIIa)
CD42a (GPIX), CD42b (GPIb)
![Page 18: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/18.jpg)
H1 shRNA EF1a GFP
Silencing HLA expression
T CA
A
GAG
5′- GAATGGAGAGAGAATTGAA
3′- TTCTTACCTCTCTCTTAACTT
T
A
HLA class I-specific silencing
Figueiredo et al, J mol Med, 2006
Figueiredo et al, Transfusion, 2007
Figueiredo et al, BioMed Res Int, 2013
Wiegmann & Figueiredo et al, Biomaterials, 2014
![Page 19: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/19.jpg)
Polyploidy of differentiated megakaryocytes
PBMCs CD41+ shRNA_NS CD41+ shRNA_β2m
35% 33%0,1%
Ce
ll c
ou
nt
2n4n
8n
16n
PI HLA class I silencing HLA class I silencing HLA class I silencing HLA class I silencing
64%
![Page 20: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/20.jpg)
shNS shβ2mNC
white bar = 50µm
shNS shβ2misotype
29.5 % 33.7 %0.0 %
ProPLTsProPLTsProPLTsProPLTs
PLTsPLTsPLTsPLTs
ProPLT/ PLT-production by differentiated MKs C
D42a
CD61
29.5 % 33.7 %0.0 %
Cell c
ou
nt
PAC-1
shNS + ADP shβ2m + ADPshNS
25.1% 29.4%2.0%
(n = 4)
Gras & Figueiredo et al. Hum Gen Ther, 2013
![Page 21: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/21.jpg)
HLA-universal MKs protected from antibody-mediated cytotoxicity
sh
NS
NC PC aHLA03
shβ
2m
(n = 4, ***p<0.001)
![Page 22: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/22.jpg)
HLA-universal MKs & PLTs prevent PLT refractoriness in a mouse model
NSG NSG
antiHLA ab
shNS shβ2mNC (ab only) ab + shNS ab + shβ2m
![Page 23: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/23.jpg)
HLA-universal PLTs prevent PLT refractoriness in a mouse model
huC
D42a
shNS shβ2mIsotype control
Human PLTs in the circulation of NSG miceHuman PLTs in the circulation of NSG miceHuman PLTs in the circulation of NSG miceHuman PLTs in the circulation of NSG mice
huCD61
huC
D42a
NC (ab only) ab + shNS ab + shβ2m
(n = 3, *p<0.05, **p<0.01)
Gras & Figueiredo et al. Hum Gen Ther, 2013
![Page 24: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/24.jpg)
Induced pluripotent Stem (iPS) cells as unilimited cell sources
Yamanaka S. Nature Medicine 2009.
![Page 25: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/25.jpg)
Differentiation of iPSCs toward HLA-universal PLTs
iPSC colony Silencing HLA expression iPSC cultured in monolayer
Orbital shaker Megakaryocyte andPlatelet formation
BMP-4VEGF
TPO
Mesoderm
Megakaryocytes
Hematopoiesis/MK
SCFIL-3TPO
Xenofree conditions
![Page 26: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/26.jpg)
Generation of HLA-universal iPSC lines
shNS shß2m
NC shβ2m
Co
un
ts
SSEA4
Tra-1-60Bef
ore T
d P1 P5
P10 P15
0
50
100
150shNS
shß2m
% H
LA
exp
ressio
n
Monolayer in Laminin
Co
un
ts
![Page 27: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/27.jpg)
CD
42
a
isotype day 12
0.2 % 7.3 %
Generation of HLA-universal Megakaryocytes
MKs
CD
42
a
CD41
day 19 day 26
82.1 % 44.6 %
shN
S
shß2m
0
20
40
60
80
100
% H
LA
exp
ressio
n
![Page 28: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/28.jpg)
Differentiation of Platelets
shβ2mNS
13.4 %18.6 %
CD
42a
CD61
CD
42a
![Page 29: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/29.jpg)
Co
un
ts
Non-stimulated ADP + Thrombin
iPSC-derived Platelets respond to external stimuli
CD62P
![Page 30: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/30.jpg)
MKsmembrane
PLTs
Large-scale production of platelets in bioreactors
CD
42
a
23.8 %
CD61
![Page 31: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/31.jpg)
Summary
• The generation of in vitro pharmed genetically modified platelets isfeasible.
• IPSC serve as an unlimited cell source for the large-scale productionof platelets.
• Universal platelets bring the concept of Universal cells one stepcloser to reality.
![Page 32: Generation of HLA universal platelets for regenerative applications · antiHLA ab NC (ab only) shNS sh β2m ab + shNS ab + sh β2m. HLA-universal PLTs prevent PLT refractoriness in](https://reader031.vdocuments.us/reader031/viewer/2022022115/5c73f59f09d3f2123b8bdecd/html5/thumbnails/32.jpg)
Institute for Transfusion Medicine, Hannover Medical School, Germany.Rainer Blasczyk Dominca RatusznyLaura Schlahsa Haijiao ZhangAnn-Kathrin Börger Stefanie VahlsingLilia Goudeva
Helmholtz Center for Infection Research, Braunschweig, GermanyCarlos GuzmanKai Schulze
Acknowledgements
Institute of Experimental Hematology, Hannover Medical School, HannoverThomas Moritz, Axel Schambach Nico LachmannMania Ackermann
LEBAO, Hannover Medical School, HannoverUlrich MartinStefanie WunderlichLena Engels
Stiftung für
Transfusionsmedizin